Wall Street rebounds as tech stocks surge, with the S&P 500 up 0.5% amid easing trade tensions and strong corporate earnings.

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

HOLLY SPRINGS, N.C. (WTVD) -- A global biotech company is celebrating its growing footprint in the Triangle. An official ribbon-cutting ceremony took place Friday for Amgen's new manufacturing ...

Providers report increased suppression of abortion-related content, with Meta citing pharmaceutical drug rules and "over ...

Company Logo Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "USA Directory of Biotechnology Companies 2025" has been added to ResearchAndMarkets.com's offering. The new USA Directory of ...

San Diego’s biggest venture capital deal of 2024 wasn’t an AI-driven firm or a biotech company. It wasn’t even a high tech startup. It was Vuori, the homegrown retail startup that’s valued ...

clinical-stage companies. But local biotech leaders see signs of change in 2025. Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to ...

Look at recent big pharma asset acquisitions and new biotech company launches, and you might spot a common theme: The drugs at the heart of these deals were originally developed in China.

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

Passage of the Act would be a significant first step in protecting Americans and American companies from malicious foreign influence in biotechnology, especially from China. The problem is we ...

Credit: uniquepixel via Getty Images. Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development of ICP-B02, a CD20×CD3 bispecific ...

Not only that, but activist investor Carl Icahn boosted his stake in a petroleum refiner, and another biotech company also had a beneficial owner return to the buy window. Let’s take a quick ...